Loading stock data...
Iterum Therapeutics plc (ITRM) Stock Price, Chart & Analysis
Iterum Therapeutics plcITRM
Market Closed$0.73
+$0.00+0.11%
ITRM Market Indicators
Very Bearish
Market Sentiment
Historical Price Chart
View the historical price chart for ITRM to analyze trends and spot opportunities. Use our interactive chart to compare past performance and make informed decisions.
Iterum Therapeutics plc (ITRM)
Loading chart data...
Is Iterum Therapeutics plc (ITRM) Stock a Buy in 2025?
NO
HOLD
Score: 50/100
No, ITRM stock may not be the best buy in 2025 based on our comprehensive analysis.
Comprehensive analysis of whether ITRM stock is a good investment in 2025, including growth drivers, valuation metrics, risk factors, and analyst recommendations.
Growth Drivers
- Healthcare sector momentum
Valuation Considerations
- Analyst price targets suggest 856.3% upside potential
- Small-cap with higher growth potential and volatility
Risk Factors
- Healthcare sector cyclicality
- Small-cap liquidity and volatility risks
Analyst Consensus
Buy Ratings:0
Hold Ratings:2
Sell Ratings:0
Avg. Price Target:$7.00
Upside Potential:856.3%
Investment Summary
ITRM presents a mixed investment profile for 2025. The company shows strong growth drivers including healthcare sector momentum, though analyst price targets suggest 856.3% upside potential.
Analyst sentiment is mixed with 0 buy ratings vs 0 sell ratings.
Investors should weigh the growth potential against the identified risks, particularly healthcare sector cyclicality, and consider their own risk tolerance and investment timeline.
Final Recommendation
HOLD
Recommendation Score
Overall Score:50/100
Hold
Key Factors
- Very significant upside potential
- Small-cap risks
- Extremely high debt relative to market cap
- Debt-to-Market-Cap Ratio: 103.1% (Extremely High)
Investment Decision
Based on our comprehensive analysis of ITRM's financial metrics, growth prospects, valuation, analyst sentiment, and risk factors, we recommend a HOLD. This recommendation considers the company's current fundamentals, market position, and future growth potential while accounting for identified risks and market conditions.
How to Invest in itrm Stock?
Quick Investment Insights for itrm
High Volatility (Beta: 2.85)
1. Research Fundamentals
Analyze financial statements and market position
2. Technical Analysis
Review price charts and technical indicators
3. Risk Assessment
Evaluate market and company-specific risks
Company Profile
Iterum Therapeutics plc
Healthcare
Biotechnology
Iterum Therapeutics plc, a pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States. The company offers ORLYNVA...
Employees
9
Market Cap
$31.08M